期刊文献+

探讨早期糖皮质激素冲击疗法对视神经脊髓炎视功能恢复的影响 被引量:6

Objective the Investigate Effect of Glucocorticoid Therapy on the Recovery of Visual Function in Patients With Neuro Myelitis Optica
下载PDF
导出
摘要 目的探讨分析视神经脊髓炎使用早期糖皮质激素冲击疗法后视功能恢复情况。方法对我院42例视神经脊髓炎患者进行分析研究,共有患眼50只,分成对照组和观察组,均有21例。观察组使用甲泼尼龙,地塞米松注射,泼尼松片口服治疗;对照组使用地塞米松注射,泼尼松片口服治疗,对比临床治疗效果。结果经过治疗后,观察组的临床治疗有效率是80.77%,对照组是66.67%,结果差异存在统计学意义(P<0.05);观察组视网膜神经纤维层(RNFL)厚度高于对照组,结果差异存在统计学意义(P<0.05);观察组Barthel指数评分高于对照组(P<0.05)。结论视神经脊髓炎使用早期糖皮质激素冲击疗法的效果突出,患者视力和日常生活能力有改善。 Objective To investigate and analysis the visual function recovery early use of methylprednisolone in neuro myelitis optica. Methods To analysis the 42 cases of neuro myelitis optica patients in our hospital. Both 50 eyes were divided into control group and observation group, 21 cases in earch group. The observation group using methylprednisolone, dexamethasone, prednisone; control group with dexamethasone injection, prednisone, compared the clinical treatment effect. Results After treatment, the clinical effective rate in the treatment group was 80.77%, the control group was 66.67%, there was a significant difference between the results of the observation group(P〈0.05); retinal nerve fiber layer(RNFL) thickness is higher than the control group, there were significant differences(P〈0.05); the observation group barthel score higher than the control group(P〈0.05). Conclusion The effect of glucocorticoid therapy in early stage of optic nerve myelitis is prominent, and the visual acuity and daily living ability of the patients have been improved significantly.
作者 董智慧
出处 《中国卫生标准管理》 2017年第3期64-65,共2页 China Health Standard Management
关键词 甲泼尼龙 视神经脊髓炎 视功能 methylprednisolone optic myelitis visual function
  • 相关文献

参考文献7

二级参考文献95

  • 1Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spec-trum of neuromyelitis optica [J]. Lancet Neurol, 2007, 6(9): 805-815. 被引量:1
  • 2Matiello M, Jacob A, Wingerchuk DM, et al. Neuromyelitis op- tica [J]. Curr Opin Neurol, 2007, 20(3): 255-260. 被引量:1
  • 3Lennon VA, Wingerchuk DM, Kryzer T J, et al. A serum autoan- tibody marker of neuromyelitis optica: distinction from multi- ple sclerosis [J]. Lancet, 2004, 364(9451): 2106-2112. 被引量:1
  • 4Lennon VA, Kryzer TJ, Pittock S J, et al. IgG marker of op- tic-spinal multiple sclerosis binds to the aquaporin-4 water channel [J]. J Exp Med, 2005, 202(4): 473-477. 被引量:1
  • 5Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromye- litis optica [J]. Ann Neurol, 2009, 66(3): 425-428. 被引量:1
  • 6Misu T, Fujihara K, Nakashima I, et al. Pure optic-spinal form of multiple sclerosis in Japan [J]. Brain, 2002, 125(Pt 11): 2460-2468. 被引量:1
  • 7Keegan M, Pineda AA, Mcclelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: predictors of re- sponse [J]. Neurology, 2002, 58(1): 143-146. 被引量:1
  • 8Wingerchuk DM, Lennon VA, Pittock S J, et al. Revised diag- nostic criteria for neuromyelitis optica [J]. Neurology, 2006, 66 (10): 1485-1489. 被引量:1
  • 9Wingerchuk DM. Neuromyelitis optica: new findings on patho- genesis [J]. Int Rev Neurobiol, 2007, 79: 665-688. 被引量:1
  • 10Kira J. Neuromyelitis optica and asian phenotype of multiple sclerosis [J]. Ann N YAcad Sci, 2008, 1142: 58-71. 被引量:1

共引文献25

同被引文献46

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部